Singapore Medical Group (“SMG”) share prices has fallen by a whopping 44.1% from its peak of S$0.715 on 17 July 2017 to only S$0.400 as at 8 January 2019. This is despite Q3 2018 YTD revenue growth of 27.8% and net profit after tax growth of 66.7% relative to FY2017 Q3 YTD. What is even more astonishing is that the share price has languished albeit the explosive growth of revenue and net profit attributable to shareholders over the past 3 years. Taking into account the previous rights issue at S$0.48 on 4 July 2018, investors who bought in at the current pricing of S$0.40 would have gained an immediate discount of 16.7% to the fair value of cash on hand fair where the bulk of the recent S$6.6Mil cash raised is still held in bank and only S$2.2Mil were utilized as at 31 Dec 2018. Business Activities of...